C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 115,450 shares of the medical equipment provider's stock, valued at approximately $60,260,000. Intuitive Surgical accounts for about 2.1% of C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors' holdings, making the stock its 9th largest holding.

Other hedge funds have also recently added to or reduced their stakes in the company. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth about $26,000. Godsey & Gibb Inc. boosted its holdings in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical in the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical during the 3rd quarter worth approximately $38,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Price Performance

Shares of ISRG stock traded up $4.16 during midday trading on Friday, reaching $595.55. 1,188,781 shares of the company traded hands, compared to its average volume of 1,979,754. The firm has a market cap of $212.12 billion, a PE ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. The firm's 50 day simple moving average is $559.48 and its two-hundred day simple moving average is $519.66. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Remove Ads

Insider Buying and Selling

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the company's stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company's stock, valued at $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 6,348 shares of company stock valued at $3,587,582. 0.90% of the stock is owned by insiders.

Analyst Ratings Changes

ISRG has been the topic of several research analyst reports. Morgan Stanley upgraded shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Citigroup boosted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a report on Friday, January 24th. Stifel Nicolaus raised their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a research note on Thursday, December 5th. Leerink Partners boosted their price objective on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Finally, JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.